Research & Stats | Asthma Foundation NZ

In this section

Filter by topic:

All Research Asthma COPD Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Obesity Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma :

Prof Jonathan A Bernstein, MD, Prof J Christian Virchow, MD, Kevin Murphy, MD, Jorge Fernando Maspero, MD, Joshua Jacobs, MD, Prof Yochair Adir, MD et al.

14 February, 2020

Respiratory Research Review Issue 176

Is Computed Tomography Airway Count Related to Asthma Severity and Airway Structure and Function?:

Rachel L. Eddy, Sarah Svenningsen, Miranda Kirby, Danielle Knipping, David G. McCormack, Christopher Licskai, Parameswaran Nair and Grace Parraga

30 December, 2019

Respiratory Research Review Issue 176

Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma:

Gráinne d'Ancona, Joanne Kavanagh, Cris Roxas, Linda Green, Mariana Fernandes et al.

7 May, 2020

Respiratory Research Review Issue 176

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK:

Trung N. Tran, Elizabeth Kind, Rajiv Sarkar, Cassandra Nan, Annalisa Rubino, Caroline O'Leary, Ruvimbo Muzwidzwa, Laura Belton, Jennifer K. Quint

4 June, 2020

Respiratory Research Review Issue 176

Mepolizumab effectiveness and identification of super-responders in severe asthma:

Erin S. Harvey, David Langton, Constance Katelaris, Sean Stevens, Claude S. Farah, Andrew Gillman, John Harrington, Mark Hew, Vicky Kritikos, et al.

21 May, 2020

Respiratory Research Review Issue 176

Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma:

Ingrid Maijers, Nethmi Kearns, James Harper, Mark Weatherall, Richard Beasley

2 January, 2020

Respiratory Research Review Issue 176

Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma:

Prof Ian D Pavord, FMedSci, Mark Holliday, BSc, Prof Helen K Reddel, PhD, Irene Braithwaite, PhD, Stefan Ebmeier, BMBCh, Prof Robert J Hancox, MD et al.

11 March, 2020

Respiratory Research Review Issue 176

Patient preferences for symptom-drive or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial :

Christina Baggott, Helen K. Reddel, Jo Hardy, Jenny Sparks, Mark Holliday, Andrew Corin, Barney Montgomery, Jim Reid, Davitt Sheahan, Robert J. Hancox, Mark Weatherall, Richard Beasley, James Fingleton

16 April, 2020

Respiratory Research Review Issue 176

Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme:

Bright I. Nwaru, Magnus Ekström, Pål Hasvold, Fredrik Wiklund, Gunilla Telg and Christer Janson

16 April, 2020

Respiratory Research Review Issue 176

Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study :

Elise M.A. Slob, Bronwyn K. Brew, Susanne J.H. Vijverberg, Chantal J.A.R. Kats , Cristina Longo, Mariëlle W. Pijnenburg, Toos C.E.M. van Beijsterveldt, Conor V. Dolan, Meike Bartels, Patrick Magnusson, Paul Lichtenstein, Tong Gong, Gerard H. Koppelman, Catarina Almqvist, Dorret I. Boomsma and Anke H. Maitland-van der Zee

23 April, 2020

Respiratory Research Review Issue 176